20/20 Biolabs

AIDXNasdaq United States Health Care Precision Instruments

Market cap

$2.473 M

$0.19 -18.86%

Close of 6 Nov 2026

As of 6 Nov 2026, 20/20 Biolabs (AIDX) has a market capitalization of $2.47M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$2.05M

#3391 by revenue

Earnings

-$3.74M

Loss-making

Shares outstanding

10,611,528

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Precision Instruments, ranked by market cap

All 3 →

#1UL SolutionsULS$15.5B
#2NeogenomicsNEO$2.13B
#320/20 BiolabsAIDX$2.47M

What if 20/20 Biolabs were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,112,399

Per share 11,418,374× higher

Bitcoin $1.53T

$114,298.24

Per share 617,828× higher

Apple $5.02T

$375,230.46

Per share 2,028,273× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for 20/20 Biolabs are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.